$21.47
-0.52-2.36%
At close: -
$21.47
0.000.00%
After Hours: Jan 17, 4:00 PM EDT
Comments
Loading...
Enliven Therapeutics (NASDAQ:ELVN) Stock, Earnings Estimates, EPS, And Revenue
Enliven Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS Estimate
$-0.520
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Enliven Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Enliven Therapeutics (ELVN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.48 | $-0.50 | 4.00 % |
| Q2 | 2024-08-13 | $-0.41 | $-0.55 | 25.4 % |
| Q1 | 2024-05-14 | $-0.54 | $-0.57 | 5.26 % |
| Q4 | 2024-03-14 | $-0.47 | $-0.54 | 13.0 % |
Enliven Therapeutics (ELVN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Enliven Therapeutics (NASDAQ:ELVN) reporting earnings?
Enliven Therapeutics (ELVN) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Enliven Therapeutics (NASDAQ:ELVN)?
The Actual EPS was $-0.48, which beat the estimate of $-0.50.
What were Enliven Therapeutics’s (NASDAQ:ELVN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.